Gurbel PA, Fox KAA, Tantry US, Ten Cate H, Weitz JI (2019) Combination antiplatelet and oral anticoagulant therapy in patients with coronary and peripheral artery disease. Circulation 139:2170–2185

Article  CAS  PubMed  Google Scholar 

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L (2011) APPRAISE-2 investigators: Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708

Article  CAS  PubMed  Google Scholar 

Machlus KR, Cardenas JC, Church FC, Wolberg AS (2011) Causal relationship between fyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 117:4953–4963

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silvain J, Collet JP, Guedeney P, Varenne O, Nagaswami C, Maupain C, Empana JP, Boulanger C, Tafflet M, Manzo-Silberman S, Kerneis M, Brugier D, Vignolles N, Weisel JW, Jouven X, Montalescot G, Spaulding C (2017) Thrombus composition in sudden cardiac death from acute myocardial infarction. Resuscitation 113:108–114

Article  PubMed  Google Scholar 

Undas A, Podolec P, Zawilska K, Pieculewicz M, Jedliński I, Stepień E, Konarska-Kuszewska E, Weglarz P, Duszyńska M, Hanschke E, Przewlocki T, Tracz W (2009) Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke. Stroke 40:1499–1501

Article  CAS  PubMed  Google Scholar 

Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. Framingham Study JAMA 258:1183–1186

CAS  PubMed  Google Scholar 

Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE (2000) D’Agostino RB Sr. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring Population. Circulation 102:1634–1638

Article  CAS  PubMed  Google Scholar 

Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study. J Am Coll Cardiol 46:1820–1826

Article  CAS  PubMed  Google Scholar 

Gurbel PA, Bliden KP, Navickas I, Cohen E, Tantry US (2007) Post-coronary intervention recurrent ischemia in the presence of adequate platelet inhibition by dual antiplatelet therapy: what are we overlooking? J Thromb Haemost 5:2300–2301

Article  CAS  PubMed  Google Scholar 

Gurbel PA, Bliden KP, Levy JH, Walia N, Rapista N, Cho A, Jerjian C, Tantry US (2021) Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? Blood Coagul Fibrinolysis 32:544–549

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawrence SO, Simpson-Haidaris PJ (2004) Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation. Thromb Haemost 92:234–243

Article  CAS  PubMed  Google Scholar 

Gurbel PA, Bliden KP, Tantry US, Monroe AL, Muresan AA, Brunner NE, Lopez-Espina CG, Delmenico PR, Cohen E, Raviv G, Haugen DL, Ereth MH (2016) First report of the point-of-care TEG: a technical validation study of the TEG-6S system. Platelets 27:642–649

Article  CAS  PubMed  Google Scholar 

Gurbel PA, Bliden KP, Saucedo JF, Suarez TA, DiChiara J, Antonino MJ, Mahla E, Singla A, Herzog WR, Bassi AK, Hennebry TA, Gesheff TB, Tantry US (2009) Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (clopidogrel with Eptifibatide to arrest the reactivity of platelets) study. J Am Coll Cardiol 53:648–657

Article  CAS  PubMed  Google Scholar 

Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae JS, Cho SY, Koh JS, Park Y, Hwang SJ, Gorog DA, Tantry US, Bliden KP, Gurbel PA, Hwang JY, Jeong YH (2023) Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction. Eur Heart J 44:1718–1728

Article  CAS  PubMed  Google Scholar 

Weisel JW, Litvinov RI (2017) Fibrin formation, structure and Properties. Subcell Biochem 82:405–456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harr JN, Moore EE, Ghasabyan A, Chin TL, Sauaia A, Banerjee A, Silliman CC (2013) Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 39:45–49

Article  CAS  PubMed  PubMed Central  Google Scholar